New PP on Aug 13

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

fouremm

Rank: President [?]

Points: 3330 [?]

Votes: 34 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

New PP on Aug 13

posted on Aug 19, 2019 11:07PM

On Sedar. 4 different investors from Caymans, Liechtenstein, BC and PQ subscribed for a total of 103,000 units (share + 1/2 warrant) at $2.65CDN/unit.

5 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply